Utility and improvement of liposome injections AmBisome® for clinical use

Yakugaku Zasshi

Volumn 130, Issue 3, 2010, Pages 457-461

  Sugiyama, Ikumi ^a   Kudo, Kenzo ^a   Takahashi, Katsuo ^a   Sadzuka, Yasuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

AmBisome ; Clinical environment; Liposome injection

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ARTICLE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INDUSTRY; FILTER; MEDICAL STAFF; MYCOSIS; QUESTIONNAIRE; THERAPY EFFECT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; FILTRATION; HUMANS; INFUSIONS, INTRAVENOUS; LIPOSOMES; NURSES; QUESTIONNAIRES; SOLUBILITY;

EID: 77649249992     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.457     Document Type: Article

References (11)

1. Hashida M., Takakura Y., "Seitainai Yakubutsu Soutatsu Gaku," ed. by Ikada Y., Sangyo Tosho, Tokyo, 1994, pp. 34-93.
2. Inoue K., Nojima S., "The Liposomes," ed. by Nojima S., Sunamoto J., Inoue K., Nankodo Co., Ltd., Tokyo, 1988 pp. 1-19.
3. Yasuda T., "The Liposomes," ed. by Nojima S., Sunamoto J., Inoue K., Nankodo Co., Ltd., Tokyo, 1988, pp. 246-276.
4. Adler-Moore J. P., Bone Marrow Transplant., 14, S3-S7 (1994).
5. Sau K., Mambula S. S., Latz E., Henneke P., Golenbock D. T., Levitz S. M., J. Biol. Chem., 278, 37561-37568 (2003).
6. Johnson E. M., Ojwang J. O., Szekely A., Wallace T. L., Warnock D. W., Antimicrob. Agents Chemother., 42, 1412-1416 (1998).
7. Jessip C., Reyes G., Fothergill A., McCarthy D., Rinaldi M., Messer S., Pfaller M., Ghannoum M., J. Chemother., 12, 22-29 (2000).
8. "The Japanese Pharmacopoeia, 15th edition," ed. by Pharmacopoeial Editorial Committee, Hirokawa Shoten, Tokyo, 2006, pp. 295-296.
9. Koseki N., Drug Delivery System, 22, 84-88 (2007).
10. Fujii G., Biochem., 36, 4959-4968 (1997).
11. Ishii M., J. Jpn. Soc. Hosp. Pharm., 41, 1005-1008 (2005).